This inventor holds 2 USPTO granted patents. Top assignee: Sanford Burnham Prebys Medical Discovery Institute. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Dominik Heimann: Innovator in Apoptosis Modulation
Introduction
Dominik Heimann is a notable inventor based in Hamm, Germany. He has made significant contributions to the field of biomedical research, particularly in the modulation of apoptosis through innovative compounds.
Latest Patents
Heimann holds a patent for "Inhibitor of apoptosis (IAP) protein antagonists." This patent includes compounds that modulate the activity of inhibitor of apoptosis (IAP) proteins, along with compositions and methods for utilizing these compounds effectively. His work in this area is crucial for advancing therapeutic strategies in various diseases.
Career Highlights
Heimann is affiliated with the Sanford Burnham Prebys Medical Discovery Institute, where he engages in cutting-edge research. His focus on apoptosis modulation positions him at the forefront of medical innovation.
Collaborations
He has collaborated with esteemed colleagues such as Sumit K Chanda and Peter Teriete, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Dominik Heimann's work in the field of apoptosis modulation exemplifies the impact of innovative research on medical science. His contributions continue to pave the way for new therapeutic approaches.